DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,560 | -7.5% | 308,793 | -19.1% | 0.01% | 0.0% |
| Q2 2023 | $4,930 | +11.1% | 381,618 | -15.6% | 0.01% | 0.0% |
| Q1 2023 | $4,437 | -21.5% | 452,367 | -14.9% | 0.01% | -25.0% |
| Q4 2022 | $5,653 | -94.9% | 531,335 | +4924.0% | 0.01% | – |
| Q3 2022 | $110,000 | -51.3% | 10,576 | -41.1% | 0.00% | – |
| Q2 2022 | $226,000 | -78.3% | 17,967 | -81.3% | 0.00% | -100.0% |
| Q1 2022 | $1,040,000 | +44.2% | 95,978 | +87.2% | 0.00% | 0.0% |
| Q4 2021 | $721,000 | +1342.0% | 51,270 | +902.2% | 0.00% | – |
| Q2 2021 | $50,000 | -66.4% | 5,116 | -69.6% | 0.00% | – |
| Q2 2020 | $149,000 | +292.1% | 16,814 | +150.0% | 0.00% | – |
| Q4 2019 | $38,000 | -88.9% | 6,726 | -63.4% | 0.00% | -100.0% |
| Q4 2017 | $343,000 | – | 18,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |